abstract |
A fast-dissolving pharmaceutical compositionncomprising micronized (R)-2-(4-bromo-2-fluorobenzyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine-1,2',3,5'-tetrone (hereinafter, referred to asnAS-3201). The present pharmaceutical composition hasnimproved dissolution characteristics as well as a goodnbioavailability. |